Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-28

Clinical Trial Update: Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke [Phase 4]

View source ↗

Summary

Phase 4 study by Medtronic assessed continuous cardiac monitoring to detect atrial fibrillation after cryptogenic transient ischemic attack or cryptogenic ische…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Cryptogenic Symptomatic Transient Ischemic Attack, Cryptogenic Ischemic Stroke | Phase 4 | Status: COMPLETED | Results posted: 2014-07-28